CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

HR Notices From November 14

View Comments
mattroush Matt Roush
Matt Roush joined WWJ Newsradio 950 in September 2001 to spearhead the...
Read More

MPI Research Announces New Head of Laboratory Sciences Division: Mattawan-based MPI Research, the largest single-site preclinical contract research organization worldwide, is pleased to announce that Roger N. Hayes, PhD, will be joining the company as vice president and general manager or laboratory sciences, effective Nov. 14. Hayes has held numerous leadership positions in the global life sciences industry and academia, leading teams in the development of state-of-the-art bioanalytical and analytical techniques, including mass spectrometry, chromatography, and automation in bringing medical and chemical products to market. For nearly two decades, he led strategic and research initiatives for large pharmaceutical companies that included both GLP and non-GLP preclinical studies as well as clinical trials. At Merck Research Laboratories (2000-2010), Hayes directed the regulated bioanalysis group in support of preclinical and clinical safety trials and also advanced efficiencies for method development and validation. At Parke-Davis Pharmaceuticals (1993-2000), he managed the instrumentation support department, headed the Bioanalytical Groups for both safety and discovery research, and did cutting-edge work as the leader of the Drug Metabolism Mass Spectrometry Group. Prior to that, Hayes spent several years at Procter and Gamble, where he developed new analytical technology and processes. His career is  rooted in academia, beginning at the University of Adelaide in Australia, where he received his PhD and performed innovative research in gas phase ion chemistry. From there, he went to the University of Nebraska-Lincoln, where he served as an Assistant Director/Assistant Research Professor and continued his ground-breaking research, with an emphasis on advancements in the use of mass spectrometry. Most recently (2011), he served as President, Bioanalytical Operations, at Cetero Research where he focused on establishing overall corporate direction for bioanalytical and analytical services. More at www.mpiresearch.com.

Altair Appoints Mahoney President of HiQube BI Software Division: Troy-based Altair Engineering, a provider of simulation, advanced computing and enterprise analytics software, Monday announced the appointment of Miles Mahoney as president of its HiQube business intelligence software division. Mahoney, whose nearly 20 years of experience includes officer-level positions with Crystal Decisions, Business Objects and SAS, will be responsible for setting the vision and strategy to grow HiQube’s business globally, with an emphasis on alliances with system integrators, OEM partners and value-added resellers. Mahoney joins HiQube after serving as president and COO of Denver-based EverGreen Energy, which developed the world’s most accurate tool for the scientific measurement and management of greenhouse gas emissions. There, Mahoney was responsible for global financial  performance and the company’s sales infrastructure and marketing, as well as business development relationships with Deloitte, IBM, SAP and other major independent software vendors and system integrators. Earlier, Mahoney was a vice president and general manager at SAS Institute, developing its first-ever global alliances, OEM and  channel/distribution business. As a vice president of the global channel and system integrator business at Crystal Decisions, later Business Objects, Mahoney built a world-class alliance organization from a $5 million unit into a $60 million business.  Mahoney’s career also has included positions as senior vice president at Day Corp., national sales manager for Infinium software and financial analyst for Dun and Bradstreet. He has a bachelor’s degree in finance from Montana State University and an MBA from Pepperdine University. More at www.hiqube.com.

View Comments
blog comments powered by Disqus